The American Journal of Medicine
Volume 123, Issue 2 , Pages 173-181 , February 2010

Antihypertensive Drug Persistence and Compliance Among Newly Treated Elderly Hypertensives in Ontario

  • Oded Friedman, MD

      Affiliations

    • Prosserman Centre for Health Research (Samuel Lunenfeld Research Institute, Mount Sinai Hospital), Toronto, Canada
    • Institute For Clinical Evaluative Sciences, Toronto, Canada
    • Corresponding Author InformationReprint requests should be addressed to Oded Friedman, MD, c/o Prosserman Centre for Health Research (Samuel Lunenfeld Research Institute, Mount Sinai Hospital), 60 Murray Street, Toronto, Ontario, M5G1X5 Canada
  • ,
  • Finlay A. McAlister, MD

      Affiliations

    • Division of General Internal Medicine, University of Alberta, Edmonton, Canada
  • ,
  • Lingsong Yun, MD

      Affiliations

    • Institute For Clinical Evaluative Sciences, Toronto, Canada
  • ,
  • Norman R.C. Campbell, MD

      Affiliations

    • Departments of Medicine and Pharmacology and Therapeutics, Libin Cardiovascular Institute, University of Calgary, Canada
  • ,
  • Karen Tu, MD

      Affiliations

    • Institute For Clinical Evaluative Sciences, Toronto, Canada
    • University Health Network-Toronto Western Hospital Family Medicine Centre, Toronto, Canada
    • Department of Family and Community Medicine, University of Toronto, Canada
  • ,
  • Canadian Hypertension Education Program Outcomes Research Taskforce

References 

  1. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19:1190–1196
  2. Hughes D, McGuire A. The direct costs to the NHS of discontinuing and switching prescriptions for hypertension. J Hum Hypertens. 1998;12:533–537
  3. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006;47:1039–1048
  4. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA. 2001;285:437–443
  5. Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag. 2005;1:93–106
  6. Williams J, Young W. A summary of studies on the quality of health care administrative databases in Canada. In:  Goel V,  William J,  Anderson G, et al. editor. Patterns of Health Care in Ontario: The ICES Practice Atlas. 2nd ed.. Ottawa: Canadian Medical Association; 1996;p. 339–345
  7. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512–516
  8. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–619
  9. Mustard CA, Derksen S, Berthelot JM, Wolfson M. Assessing ecologic proxies for household income: a comparison of household and neighbourhood level income measures in the study of population health status. Health Place. 1999;5:157–171
  10. Wilkins R. PCCF+Version 4J User's Guide: Automated Geographic Coding Based on the Statistics Canada Postal Code Conversion Files, Including Postal Codes through September 2006. Ottawa: Health Analysis and Measurement Group, Statistics Canada; 2007;Report No.: 82F0086-XDB
  11. du Plessis V, Beshiri R, Bollman R, et al. Definitions of “Rural”. Ottawa: Statistics Canada; 2002;Agriculture and Rural Working Paper Series, No. 61
  12. Tu K, Campbell NR, Duong-Hua M, McAlister FA. Hypertension management in the elderly has improved: Ontario prescribing trends, 1994 to 2002. Hypertension. 2005;45:1113–1118
  13. Burke TA, Sturkenboom MC, Lu SE, et al. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens. 2006;24:1193–1200
  14. Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37
  15. Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens. 2005;23:2093–2100
  16. Caro JJ, Speckman JL, Salas M, et al. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999;160:41–46
  17. Marentette MA, Gerth WC, Billings DK, Zarnke KB. Antihypertensive persistence and drug class. Can J Cardiol. 2002;18:649–656
  18. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:671–681
  19. Degli Esposti L, Degli Esposti E, Valpiani G, et al. A retrospective, population-based analysis of persistence with antihypertensive drug therapy in primary care practice in Italy. Clin Ther. 2002;24:1347–1357discussion 1346
  20. Wogen J, Kreilick CA, Livornese RC, et al. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Manag Care Pharm. 2003;9:424–429
  21. Bourgault C, Senecal M, Brisson M, et al. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens. 2005;19:607–613
  22. Elliott WJ, Plauschinat CA, Skrepnek GH, Gause D. Persistence, adherence, and risk of discontinuation associated with commonly prescribed antihypertensive drug monotherapies. J Am Board Fam Med. 2007;20:72–80
  23. Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–1559
  24. van Wijk BL, Shrank WH, Klungel OH, et al. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008;26:145–153
  25. Di Martino M, Veronesi C, Degli Esposti L, et al. Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in Italy. J Hum Hypertens. 2008;22:51–53
  26. Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10(7 Pt 1):697–704
  27. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:26–32
  28. Thorpe CT, Bryson CL, Maciejewski ML, Bosworth HB. Medication acquisition and self-reported adherence in veterans with hypertension. Med Care. 2009;47:474–481
  29. Hyre AD, Krousel-Wood MA, Muntner P, et al. Prevalence and predictors of poor antihypertensive medication adherence in an urban health clinic setting. J Clin Hypertens (Greenwich). 2007;9:179–186
  30. Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther. 1997;19:1446–1457discussion 1424-1425
  31. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–1841
  32. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA. 2007;297:177–186
  33. Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121–1123
  34. DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40:794–811

 Funding: Alberta Heritage Foundation for Medical Research.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)00797-9

doi: 10.1016/j.amjmed.2009.08.008

The American Journal of Medicine
Volume 123, Issue 2 , Pages 173-181 , February 2010